Tunstall Healthcare: Emil Peters

Emil Peters

Health and care technology company, Tunstall Healthcare, has announced the appointment of Emil Peters as group chief executive with effect from 16 May.

Tunstall works within the health, care and housing sectors, providing a range of technology-enabled solutions to vulnerable people, improving quality of life and enabling independent living.

Peters’ appointment follows the recent announcement that Gary Steen has joined the company as chief technology officer from telecoms blockbuster TalkTalk.

Peters said: “It is an honour to be joining such a long-standing and reputable organisation. The work that the team at Tunstall has done to date is remarkable, the technology that they are developing and delivering is life-changing to some of our most vulnerable members of society. I am excited to learn from my new colleagues and together with them, grow the business into a true deliverer of solutions to help and enable people globally, to live better and independently for longer.”

Peters joins Tunstall from Cerner Corporation where he held the position of international president, managing all territories outside of the US. A Cerner veteran, he joined the company almost 25 years ago and held multiple positions across different directorates and markets until his appointment as president in 2017, having lived in Belgium, Spain, the USA and the UK. He brings experience in data integration in a healthcare setting as well as first-hand experience in the development and adoption of advanced software solutions across healthcare structures in multiple geographies.

Peter Nicklin, chairman of Tunstall, commented: “As we move forward past our 65th year anniversary and continue to expand our digital technology capabilities, I am thrilled to have Peters leading the charge. His leadership experience is perfectly placed to empower the Tunstall team to deliver products and services that, ultimately, save and prolong lives.”

Join our mailing list

Stay up to date with all our events, awards and publications.

Information you provide us with will be kept private at all times, and will be used for communication and research purpose only.